224 related articles for article (PubMed ID: 1426903)
1. [Refractory effect and alloimmunization after transfusion of thrombocytes].
Volkova RI; Agranenko VA
Gematol Transfuziol; 1992 Feb; 37(2):16-21. PubMed ID: 1426903
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects of platelet transfusions.
Murphy MF; Waters AH
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
Trial to Reduce Alloimmunization to Platelets Study Group
N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
Sintnicolaas K; van Marwijk Kooij M; van Prooijen HC; van Dijk BA; van Putten WL; Claas FH; Novotny VM; Brand A
Blood; 1995 Feb; 85(3):824-8. PubMed ID: 7833483
[TBL] [Abstract][Full Text] [Related]
5. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
[TBL] [Abstract][Full Text] [Related]
6. A specific assay for anti-HLA antibodies: application to platelet donor selection.
Millard FE; Tani P; McMillan R
Blood; 1987 Nov; 70(5):1495-9. PubMed ID: 3311206
[TBL] [Abstract][Full Text] [Related]
7. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
Saris A; Pavenski K
Transfus Med Rev; 2020 Oct; 34(4):250-257. PubMed ID: 33127210
[TBL] [Abstract][Full Text] [Related]
8. Transfusion therapy with platelets and leukocytes.
Luban NL
Pediatr Ann; 1983 Jun; 12(6):437-44. PubMed ID: 6348681
[TBL] [Abstract][Full Text] [Related]
9. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization.
Murphy MF; Metcalfe P; Thomas H; Eve J; Ord J; Lister TA; Waters AH
Br J Haematol; 1986 Mar; 62(3):529-34. PubMed ID: 3954967
[TBL] [Abstract][Full Text] [Related]
10. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
Sniecinski I; O'Donnell MR; Nowicki B; Hill LR
Blood; 1988 May; 71(5):1402-7. PubMed ID: 3282572
[TBL] [Abstract][Full Text] [Related]
11. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
[TBL] [Abstract][Full Text] [Related]
12. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
Levy L; Woodfield DG
N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
[TBL] [Abstract][Full Text] [Related]
13. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
Amemiya Y
Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
[TBL] [Abstract][Full Text] [Related]
14. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
[TBL] [Abstract][Full Text] [Related]
15. Platelet transfusions: the problem of refractoriness.
Murphy MF; Waters AH
Blood Rev; 1990 Mar; 4(1):16-24. PubMed ID: 2182145
[TBL] [Abstract][Full Text] [Related]
16. Alloimmunization by leukocyte-rich or leukocyte-poor random single donor platelets.
Gmür J; Burger J; Sauter C; Oelz O; Frick PG
Prog Clin Biol Res; 1990; 337():45-8. PubMed ID: 2191337
[No Abstract] [Full Text] [Related]
17. Prevention of platelet alloimmunization.
Slichter SJ
Prog Clin Biol Res; 1986; 211():83-116. PubMed ID: 3515365
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.
Murphy MF; Brozovic B; Murphy W; Ouwehand W; Waters AH
Transfus Med; 1992 Dec; 2(4):311-8. PubMed ID: 1339584
[TBL] [Abstract][Full Text] [Related]
19. Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.
Snyder EL
Yale J Biol Med; 1990; 63(5):419-27. PubMed ID: 2293501
[TBL] [Abstract][Full Text] [Related]
20. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]